Tribunal clarifies duty assessment for physician samples, emphasizing consistency in valuation methods

The Tribunal ruled in favor of the appellant in a case concerning the assessment of duty on physician samples manufactured for a principal manufacturer. The Tribunal clarified that duty should be assessed based on the pro-rata value of regular packs when samples are manufactured by a medicament unit for free distribution to doctors. However, if the samples are not made by the regular pack manufacturer, duty should be determined based on transaction or contracted value. The decision overturned the revenue's position, emphasizing the importance of consistent duty assessment methods in such situations.

---

---

Issues: Assessment of duty on physician samples manufactured by an appellant for a principal manufacturer.

Analysis:
The dispute in the appeals revolved around the assessment of duty on physician samples manufactured by the appellant for a principal manufacturer. The revenue contended that duty should be paid on a pro-rata basis corresponding to the value of the regular packs, resulting in raised differential duty and confirmed demand against the appellant. However, the Tribunal, after considering the arguments from both sides, referred to the Larger Bench decision in the case of Cadila Pharmaceuticals Ltd. The Tribunal clarified that physician samples manufactured by a medicament manufacturing unit, intended for free distribution to doctors, should be assessed to duty based on the pro-rata value of the regular packs. Nevertheless, if such samples are not manufactured by the regular pack manufacturer, they should be assessed to duty based on the transaction value or contracted value in accordance with the purchase orders. This interpretation was supported by various decisions favoring the assessee, including those listed in the judgment. Consequently, the Tribunal set aside the impugned order and allowed all the appeals, providing consequential relief to the appellant.

In conclusion, the Tribunal's decision clarified the assessment of duty on physician samples manufactured by the appellant for a principal manufacturer. By referencing relevant legal precedents and considering the specific circumstances of the case, the Tribunal ruled in favor of the appellant, overturning the revenue's contention regarding the pro-rata basis for duty assessment. The judgment highlighted the importance of assessing duty based on the transaction value or contracted value when physician samples are not manufactured by the regular pack manufacturer, ensuring a fair and consistent application of excise duty regulations in such scenarios.

---